Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
収録刊行物
-
- The Lancet Oncology
-
The Lancet Oncology 16 (7), 830-838, 2015-07
Elsevier BV